|
| OROTIC ACID MONOHYDRATE Basic information |
Product Name: | OROTIC ACID MONOHYDRATE | Synonyms: | 1,2,3,6-TETRAHYDRO-2,6-DIOXO-4-PYRIMIDINECARBOXYLIC ACID, HYDRATE;2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINECARBOXYLIC ACID HYDRATE;2,6-DIOXO-1,2,3,6-TETRAHYDRO-4-PYRIMIDINECARBOXYLIC ACID MONOHYDRATE;2,4-DIHYDROXYPYRIMIDINE-6-CARBOXYLIC ACID HYDRATE;2.4-DIHYDROXYPYRIMIDINE-6-CARBOXYLIC ACID MONOHYDRATE;Orotic acid Monohydrate 97%;Orotic acid Mo;1,2,3,4-Tetrahydro-2,4-dioxo-6-pyrimidine-carboxylicacidmonohydrate | CAS: | 50887-69-9 | MF: | C5H6N2O5 | MW: | 174.11 | EINECS: | 610-580-2 | Product Categories: | Building Blocks;C4 to C5;Chemical Synthesis;Heterocyclic Building Blocks;Nutrition Research;Other Biochemical;Phytochemicals by Chemical Classification;Pyrimidines;Miscellaneous Natural Products;Heterocyclic Compounds;Biochemistry;Nucleobases and their analogs;Nucleosides, Nucleotides & Related Reagents;pharmaceutical | Mol File: | 50887-69-9.mol | |
| OROTIC ACID MONOHYDRATE Chemical Properties |
Melting point | >300 °C(lit.) | storage temp. | Sealed in dry,Room Temperature | solubility | Aqueous Base (Slightly), DMSO (Slightly) | form | Crystalline Powder | color | White to off-white | Water Solubility | Soluble in water (1.7 mg/ml), and ammonium hydroxide. Insoluble in chloroform. | Merck | 14,6876 | BRN | 383901 | InChI | InChI=1S/C5H4N2O4.H2O/c8-3-1-2(4(9)10)6-5(11)7-3;/h1H,(H,9,10)(H2,6,7,8,11);1H2 | InChIKey | YXUZGLGRBBHYFZ-UHFFFAOYSA-N | SMILES | C1(C(=O)O)NC(NC(=O)C=1)=O.O | CAS DataBase Reference | 50887-69-9(CAS DataBase Reference) |
Hazard Codes | Xi | Risk Statements | 36/37/38 | Safety Statements | 26-36 | WGK Germany | 3 | RTECS | RM3180000 | TSCA | Yes | HS Code | 29335990 |
| OROTIC ACID MONOHYDRATE Usage And Synthesis |
Chemical Properties | white to off-white crystalline powder | Uses | Orotic Acid is used in the preparation of therapeutic agents for chronic obstructive pulmonary disease (COPD) treatment. | Uses | Orotic acid hydrate is used in cosmetic and food industry. It is also used as a pharmaceutical intermediate. | Purification Methods | It crystallises from water. The anhydrous acid [65-86-1] M 156.1 has m 245-246o(dec). [Nye & Mitchell J Am Chem Soc 69 1382 1947, Beilstein 25 III/IV 1759.] |
| OROTIC ACID MONOHYDRATE Preparation Products And Raw materials |
|